Stock INAB IN8BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus IN8bio, Inc.

Equities

INAB

US45674E1091

Real-time Estimate Cboe BZX
Other stock markets
 11:55:04 2024-06-03 am EDT 		5-day change 1st Jan Change
1.055 USD -11.34% Intraday chart for IN8bio, Inc. +1.43% -22.83%
May. 24 IN8bio Plans to Report Improvement in Progression-Free Survival of Newly Diagnosed Patients With Glioblastoma Multiforme MT
May. 13 HC Wainwright Adjusts Price Target on IN8bio to $12.50 From $14, Keeps Buy Rating MT

Evolution of the average Target Price on IN8bio, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f385b1b22015cd71594510585a68ae81.35gcihpKba8WKumKiAMSM4kJWxMjiiQcTRqvZvn7nZY.iql2uF8-FJpUR6LO5FVebLxKMWtasmFdNXvbXq-w_vXtwX2nYiYq_m5H2Q~991bf94510657dcc7e834fde6e99042b

Analyst Recommendations on IN8bio, Inc.

HC Wainwright Adjusts Price Target on IN8bio to $12.50 From $14, Keeps Buy Rating MT
Laidlaw Initiates Coverage on IN8bio With Buy Rating, $7.50 Price Target MT
JonesTrading Starts IN8bio With Buy Rating, $5 Price Target MT
EF Hutton Initiates IN8bio at Buy With $8 Price Target MT
B. Riley Downgrades IN8bio to Neutral From Buy, Notes Limited Catalysts, Cash; Lowers Price Target to $3 From $9 MT
HC Wainwright Starts IN8bio at Buy with $14 Price Target MT
B. Riley Lowers IN8bio's Price Target to $9 from $19 After Revising Cost Capital Assumptions, Keeps Buy Rating MT
IN8BIO : Mizuho Securities Starts IN8bio at Buy With $12 Price Target MT
IN8BIO : B. Riley Starts IN8bio at Buy with $19 PT, Ascribes Value to Glioblastoma Multiforme Program MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.19 USD
Average target price
7.6 USD
Spread / Average Target
+538.66%
High Price Target
12.5 USD
Spread / Highest target
+950.42%
Low Price Target
5 USD
Spread / Lowest Target
+320.17%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IN8bio, Inc.

HC Wainwright
Laidlaw & Co.
JonesTrading Institutional Services
EF Hutton
B. Riley
Mizuho Securities

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INAB Stock
  4. Consensus IN8bio, Inc.